Gyre Therapeutics (GYRE) News Today → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free GYRE Stock Alerts $17.11 +0.78 (+4.78%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePublic companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last weekfinance.yahoo.com - April 27 at 9:23 AMGyre Therapeutics (NASDAQ:GYRE) Shares Gap Down to $15.41americanbankingnews.com - April 21 at 1:44 AMGyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.1%marketbeat.com - April 17 at 11:58 AMGyre Therapeutics: Under The Radar Biotech Has A Shot At MASH Approval, In Timeseekingalpha.com - April 13 at 9:04 AMGyre Therapeutics (NASDAQ:GYRE) Shares Down 9.8% marketbeat.com - April 10 at 3:46 PMGyre therapeutics director Nassim Usman sells shares worth $323,000investing.com - April 5 at 11:50 PMGyre Therapeutics Posts Loss In 2023markets.businessinsider.com - March 26 at 4:39 PMGyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 26 at 6:00 AMRNAZ TransCode Therapeutics, Inc.seekingalpha.com - March 26 at 1:26 AMGyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaumglobenewswire.com - March 21 at 7:00 AMGyre Therapeutics, Inc. (GYRE) stock forecast and price targetfinance.yahoo.com - March 12 at 2:55 PMTVTX Travere Therapeutics, Inc.seekingalpha.com - February 28 at 11:51 PMCantor Fitzgerald Downgrades RAPT Therapeutics (RAPT)msn.com - February 22 at 11:27 PMGyre Therapeutics Incmorningstar.com - December 21 at 11:51 PMGyre Therapeutics Names Han Ying As CEOmarketwatch.com - December 15 at 10:10 PMTotus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Fundingfinance.yahoo.com - December 15 at 12:09 PMGYREseekingalpha.com - December 2 at 11:24 AMGyre Therapeutics Inc GYREmorningstar.com - November 16 at 10:00 AMGyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meetingfinance.yahoo.com - November 13 at 12:03 PMGyre Therapeutics Inc.barrons.com - November 10 at 2:47 PMGyre Therapeutics, Inc. (GYRE)finance.yahoo.com - November 9 at 10:49 AM Get Gyre Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GYRE and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details GYRE Media Mentions By Week GYRE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GYRE News Sentiment▼0.440.33▲Average Medical News Sentiment GYRE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GYRE Articles This Week▼20▲GYRE Articles Average Week Get Gyre Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GYRE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANI Pharmaceuticals News Today Morphic News Today Akero Therapeutics News Today Arcus Biosciences News Today Day One Biopharmaceuticals News Today Kura Oncology News Today Ironwood Pharmaceuticals News Today Kiniksa Pharmaceuticals News Today Ligand Pharmaceuticals News Today Dynavax Technologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GYRE) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
